Scripps Translational Science Institute
53
8
16
26
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.3%
6 terminated/withdrawn out of 53 trials
81.3%
-5.3% vs industry average
0%
0 trials in Phase 3/4
19%
5 of 26 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (53)
Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid
Role: lead
The Long COVID Treatment Trial
Role: lead
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Role: lead
PRediction Of Glycemic RESponse Study
Role: lead
The Long COVID-19 Wearable Device Study
Role: lead
Role of Wrist Based Blood Pressure Monitoring in Clinical Practice
Role: lead
Molecular and Morphologic Characterization of Circulating Endothelial Cells
Role: lead
The Healthy Elderly Longevity Cohort
Role: lead
Ovarian Cancer Hemoscope Trial
Role: lead
Scripps Genomics Health Initiative
Role: lead
Genomic Investigation of Cardiovascular Diseases
Role: lead
Molecular Autopsy Study
Role: lead
Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells
Role: lead
The Biorepository for Scripps Health
Role: lead
Idiopathic Diseases of Man
Role: lead
The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry
Role: lead
Research Framework Exploring Sleep Health
Role: lead
W-PPMA for Postpartum Mothers
Role: collaborator
POWERMOM, A Healthy Pregnancy Research Community
Role: lead
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
Role: lead